"No weight for height" case detection strategies for therapeutic feeding programs: sensitivity to acute malnutrition

Benjamin Guesdon1, Alexia Couture2, Elise Lesieur3

  • 1Action Contre La Faim - France, 14-16 Boulevard Douaumont, 75854, Paris, France. bguesdon@actioncontrelafaim.org.

BMC Nutrition
|February 2, 2021
PubMed

Insights

New criteria for therapeutic feeding programs (TFPs) increase detection of severe acute malnutrition (SAM) but admit many non-malnourished children. This approach may strain resources without effectively targeting all SAM cases.

Area of Science:

  • Nutrition Science
  • Global Health
  • Pediatrics

Background:

  • Therapeutic Feeding Programs (TFPs) are crucial for treating childhood malnutrition.
  • Current eligibility criteria are being re-evaluated with new proposed methods.
  • The study compares a new MUAC+SWAZ approach with existing WHO guidelines and the Expanded MUAC approach.

Purpose of the Study:

  • To evaluate the impact of the MUAC+SWAZ criteria on TFP eligibility.
  • To compare the sensitivity and specificity of MUAC+SWAZ and Expanded MUAC for detecting wasted children.
  • To assess the demographic changes in children eligible for TFPs under different criteria.

Main Methods:

  • Analysis of data from 558 population-representative cross-sectional cluster surveys (since 2007).
  • Identification of children classified as severe acute malnutrition (SAM), moderate acute malnutrition (MAM), and wasted with stunting (WA+ST).
  • Calculation of proportions of previously eligible children excluded and non-malnourished children newly eligible under different criteria.

Main Results:

  • Both MUAC+SWAZ and Expanded MUAC increase sensitivity for detecting SAM compared to MUAC < 115mm and edema alone.
  • Increased sensitivity comes at the cost of specificity, potentially leading to a large increase in TFP size.
  • MUAC+SWAZ shows high sensitivity for wasted and stunted children (over 80%), but about half of additional children identified are not SAM or wasted and stunted.

Conclusions:

  • The MUAC+SWAZ approach may inflate TFP targets by including many non-acutely malnourished children.
  • Resource scarcity necessitates a critical review of abandoning Weight-for-Height Z-score (WHZ) and adopting alternative case detection strategies.
  • Current strategies may not be the most efficient use of limited resources for malnutrition treatment.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
85
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
128
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
204
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
463
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
109
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
108